Clinical trials
Observational Head and Neck Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 8 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
| Unknown status | 10 |
| Completed | 4 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 5 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 |
| Peking University Third Hospital | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2 |
| West China Hospital | 2 |
| Beijing Stomatological Hospital, Capital Medical University | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Chinese PLA General Hospital | 1 |
| Eye & ENT Hospital of Fudan University | 1 |
| First Affiliated Hospital of Chongqing Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Head and Neck Neoplasms | 27 |
| Colorectal Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Melanoma | 3 |
| Pancreatic Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Glioblastoma | 2 |
| Sarcoma | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Xerostomia | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.